… after at least one biologic drug has failed or caused serious … its footprint. In March 2023, Pfizer Korea added both pJIA and … . Doctors can now prescribe the drug to children with five or … Kang Min-hee, who heads Pfizer Korea’s Strategic Alliance Portfolio …

… in Lilly’s weight-loss drug. Lilly, one of the world … cardiovascular.” Among the APIs that Pfizer produces are Sildenafil and Atorvastatin … most important part of the drug,” he said. “Our expertise is …

… U.S. Food and Drug Administration employees were shown the … Shareholder Services has recommended Pfizer investors reject a proposal on … , including repeated changes to Pfizer’s cash flow targets, … . The proxy adviser added Pfizer used a “negative discretion” …

… in-house drug discovery and development unit, and Pfizer, to discover … unique partnership model with Pfizer, we will leverage Logica …  between Flagship Pioneering and Pfizer to create a new … at Pioneering Medicines and Pfizer to accelerate understanding of …

… safety, compared to conventional systemic drugs aimed at all patients diagnosed … platforms to engineer drugs that will modulate MOH-identified drug targets in … . “Their recently announced collaborations with Pfizer and Sanofi, for respectively developing …

… . This early-stage experimental drug has been tested in laboratory … as MPro, the target of Pfizer’s drug Paxlovid), JNJ-9676 uniquely … of Bedaquiline, a treatment for drug-resistant tuberculosis, which is … that this new class of drugs is also effective against …

… in-class renal tissue-targeting drugs. The collaboration provides external … to engineer drugs that will modulate MultiOmic Health Limited-identified drug targets … “Their recently announced collaborations with Pfizer and Sanofi, for respectively developing …

… pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a … lawsuit that alleged Pfizer's respiratory syncytial … the U.S. Food and Drug Administration, with GSK' … began developing its shot. Pfizer denied the allegations and argued …

… Scientific Officer and President, Pfizer Research & Development, … drug development and investment, having played a key role in Pfizer … concluded his tenure at Pfizer on March 1, 2025 … development, shaping global drug innovation at an unprecedented …

… hub for collaborative efforts between Pfizer and local Chinese researchers, … to streamline Pfizer's ability to identify promising drug candidates more … between international pharmaceutical companies like Pfizer and domestic research institutions are …